Table 5:

Multivariate Regression Analysis of Factors Associated with Initiation of Hepatitis C Antiviral Treatment among 165 Patients with Chronic Hepatitis C in an Emergency Department-Based HCV Linkage to Care Program

		Full Model	Final Model
Characteristics	Category	Odds Ratio (95% CI)	Odds Ratio (95% CI)
Age	Increasing each year	1.07 (1.01, 1.13)*	1.04 (1.00, 1.07)*
Birth Cohort	Baby Boomer	0.44 (0.15, 1.31)	N.S.
	Non-Baby Boomer	1.00
Sex	Male	0.97 (0.48, 1.93)	N.S.
	Female	1.00
Race	African American	0.88 (0.35, 2.25)	N.S.
	Other	1.00
Health Insurance	Public – Medicaid	1.25 (0.51, 3.10)	N.S.
	Public – Medicare	0.90 (0.44, 2.49)
	Private and Self-Pay	1.00
Having a PCP	Yes	2.88 (1.15, 7.23)*	2.77 (1.13, 6.83)*
	No	1.00	1.00
Injection Drug Use	Ever	0.72 (0.37, 1.39)	N.S.
	Never	1.00
Liver Fibrosis†	Advanced (F3 or higher)	1.58 (0.81, 3.09)	N.S.
	Non-Advanced or Unknown	1.00

^*p<0.05

^†Liver fibrosis staging determined by the serology test (FibroSURE) or transient elastography (FibroScan) results

PCP: Primary Care Physician